The latest price target for Alimera Sciences Inc COM NEW (NASDAQ:ALIM) was reported by Alliance Global Partners on June 25, 2024. The analyst firm set a price target for $0.00 expecting ALIM to fall to within 12 months (a possible -100.00% downside). 6 analyst firms have reported ratings in the last year.

The latest analyst rating for Alimera Sciences Inc COM NEW (NASDAQ:ALIM) was provided by Alliance Global Partners, and Alimera Sciences Inc COM NEW downgraded their neutral rating.

The last upgrade for Alimera Sciences Inc COM NEW happened on June 12, 2023 when Alliance Global Partners raised their price target to $8. Alliance Global Partners previously had a neutral for Alimera Sciences Inc COM NEW.

The last downgrade for Alimera Sciences Inc COM NEW happened on June 25, 2024 when Alliance Global Partners changed their price target from N/A to N/A for Alimera Sciences Inc COM NEW.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Alimera Sciences Inc COM NEW, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Alimera Sciences Inc COM NEW was filed on June 25, 2024 so you should expect the next rating to be made available sometime around June 25, 2025.

While ratings are subjective and will change, the latest Alimera Sciences Inc COM NEW (ALIM) rating was a downgraded with a price target of $0.00 to $0.00. The current price Alimera Sciences Inc COM NEW (ALIM) is trading at is $5.54, which is out of the analyst’s predicted range.